Abstract
The relationship between genetic engineering and the public has never been a very harmonious one. Many scientists believe that public concerns about gene therapy are simply based on misunderstandings and lack of scientific information. In this ‘deficit theory’ of the public, most difficulties in the interaction between science and the public are derived from the assumption that there is a communication gap between scientists and the public. However, public opinion research shows clearly that the various ‘publics’ have a differentiated, and generally positive perception of medical biotechnology. It is not so much lack of information, as lack of trust which explains the difficult relationship between gene therapy and society. For the future, it will be crucial not only to focus on the idea of ‘educating the public’, but to find new communicative and institutional formats to generate trust.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Abbot A . Genetic Medicine gets real Nature 2001 411: 410–412
Abbot A . Genetic Medicine gets real National Reference Center for Bioethics Literature. Hum Gene Ther. Scope Note 24, February 2000
Flanagan N . Gene therapy for cancer Gene Eng News 2001 21: 71
Bensaude-Vincent B . A genealogy of the increasing gap between science and the public Pub Understand Sci 2001 10: 99–113
Gaskell G et al. Biotechnology and the European public Nature Biotechnol 2000 18: 935–938
Priest SH . Us public opinion divided over biotechnology? Nature Biotechnol 2000 18: 939–942
Putnam R . Princeton University Press 1993
Office of Science and Technology and the Welcome Trust.. Science and the public: a review of science communication and public attitudes toward science in Britain Pub Understand Sci 2001 10: 315–330
Millstone E, Van Zwanenberg P . A crisis of trust: for science, scientists or for institutions? Nat Med 2000 6: 1307–1308
Millstone E, Van Zwanenberg P . A crisis of trust: for science, scientists or for institutions? Friedmann T. The evolution of public review and oversight mechansims in human gene transfer research: joint roles of FDA and NIN. Curr Opin Biotechnol 12: 304–307
Millstone E, Van Zwanenberg P . A crisis of trust: for science, scientists or for institutions? Gottweis H. Governing Molecules. The Discursive Politics of Genetic Engineering in Europe and in the United States. MIT Press: Cambrige, MA, 1998, pp 336–337
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Gottweis, H. Gene therapy and the public: a matter of trust. Gene Ther 9, 667–669 (2002). https://doi.org/10.1038/sj.gt.3301752
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.gt.3301752
Keywords
This article is cited by
-
Participant mothers’ attitudes toward genetic analysis in a birth cohort study
Journal of Human Genetics (2021)
-
Experiences and attitudes of residents regarding a community-based genome cohort study in Japan: a population-based, cross-sectional study
BMC Medical Genomics (2016)
-
Hype and Public Trust in Science
Science and Engineering Ethics (2013)
-
Promoting Public Awareness and Engagement in Genome Sciences
Journal of Genetic Counseling (2013)
-
Survey of US public attitudes toward pharmacogenetic testing
The Pharmacogenomics Journal (2012)